NEW YORK & BOSTON & WILMINGTON, Del.–(BUSINESS WIRE)–Pfizer Inc. (NASDAQ:PFE), MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE: MOR; NASDAQ:MOR), and Incyte (NASDAQ:INCY) today announced a clinical trial collaboration and supply agreement to investigate the immunotherapeutic combination of Pfizer’s TTI-622, a novel SIRPα-Fc fusion protein, and Monjuvi® (tafasitamab-cxix) plus lenalidomide in patients … [Read more…]

Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST SAN JOSE, Calif.–(BUSINESS WIRE)–Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “company”) today announced it has implemented a shipment hold on the distribution of its Tablo Hemodialysis System for home use pending the Food and Drug Administration’s (FDA) review and clearance of a 510(k) the … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced the Annual General Meeting of Shareholders will be held on Tuesday, June 14, 2022, at 10:00 a.m., Pacific Daylight Time. The Company has adopted a virtual format for our Annual Meeting to provide a … [Read more…]

Largest Gift in the Organization’s 112-year History Helps Assure That Children With a Musculoskeletal Condition or Injury Have the Opportunity to Grow Well and Play Well LOS ANGELES–(BUSINESS WIRE)–#luskin–Orthopaedic Institute for Children announced today that it has received a $15 million gift from Renee & Meyer Luskin, the largest gift to the organization’s endowment in … [Read more…]

– Newly Appointed Members Include Judith Campisi, Ph.D., Mario Lacouture, M.D. and Francesca Grisoni, Ph.D. SUNNYVALE, Calif.–(BUSINESS WIRE)–Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies for chronic age-related diseases targeting senescent cells that drive cellular aging, today announced the appointments of Judith Campisi, Ph.D., Francesca Grisoni, Ph.D., and Mario Lacouture, M.D., to … [Read more…]

This randomized, placebo-controlled Phase II clinical study with TOTUM•070 achieved its objective of reducing LDL cholesterol (primary endpoint) and confirmed the very good tolerance of this active substance. As early as 3 months of supplementation, the results showed a significant reduction in blood levels of LDL cholesterol (-13%) and triglycerides (-14%). Comprehensive data from the … [Read more…]

New facility will double the occupancy of the current rehabilitation center ARROYO GRANDE, Calif.–(BUSINESS WIRE)–Arroyo Grande Community Hospital (AGCH) and Kindred Rehabilitation Services (KRS), a business unit of LifePoint Health, today announced a joint venture to build and operate a new inpatient rehabilitation hospital on Dignity Health’s Arroyo Grande Community Hospital campus. The approximately 46,000-square-foot … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Clinical Trials Connect 2022” conference has been added to ResearchAndMarkets.com’s offering. The Global Clinical Trials Connect 2022 will provide a platform to discuss on the futuristic advancements in clinical trials and clinical research. This event is designed for senior-level attendees from various companies including Pharmaceutical, Bio-Tech, Bio-Pharma, CRO’s, Investigative Sites, Solution providers … [Read more…]

Partnering for Awareness on Preventable Disease Through Early Detection and Treatment NORFOLK, Va.–(BUSINESS WIRE)–UHSM Health Share, a faith-based health care nonprofit founded on Christian beliefs and values, has joined forces with two nonprofit organizations, Men’s Health Network and Healthy Men, Inc., to support the initiative and the call to action of Men’s Health Week: END … [Read more…]

National awards program honors individuals with hearing loss, advocates and hearing care professionals SOMERSET, N.J.–(BUSINESS WIRE)–Hearing aid manufacturer Oticon, Inc. has opened the call for nominations for its annual Oticon Focus on People Awards. Now in its 24th installment, the national awards program recognizes individuals who demonstrate that hearing loss does not limit a person’s … [Read more…]